Rebekah and Zappy wander through the rapidly changing world of psychedelics, emerging medical research, consciousness, addiction, trauma, and the laws that have kept many psychedelic compounds classified alongside drugs considered to have no accepted medical use.
Zappy Zapolin—filmmaker, futurist, entrepreneur, and longtime psychedelic advocate—shares why he believes the conversation around psychedelic medicine is reaching a tipping point, from psilocybin and ketamine to ibogaine and the growing push for research, access, and legal reform. Zappy has publicly advocated for moving psilocybin out of Schedule I and expanding access to psychedelic therapies. Zappy Zapolin
They explore what the research is beginning to reveal, why these substances were prohibited in the first place, what changing federal policy could mean, and the bigger question underneath all of it: What happens when something we were taught to fear begins to show therapeutic potential?
This is a conversation about medicine, consciousness, prohibition, possibility—and what can happen when culture finally becomes willing to question an old story. www.psychedelicconcierge.com